JPWO2020172605A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020172605A5
JPWO2020172605A5 JP2021549484A JP2021549484A JPWO2020172605A5 JP WO2020172605 A5 JPWO2020172605 A5 JP WO2020172605A5 JP 2021549484 A JP2021549484 A JP 2021549484A JP 2021549484 A JP2021549484 A JP 2021549484A JP WO2020172605 A5 JPWO2020172605 A5 JP WO2020172605A5
Authority
JP
Japan
Prior art keywords
seq
sequence
amino acid
molecule
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021549484A
Other languages
English (en)
Japanese (ja)
Other versions
JP7579795B2 (ja
JP2022521937A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019329 external-priority patent/WO2020172605A1/fr
Publication of JP2022521937A publication Critical patent/JP2022521937A/ja
Publication of JPWO2020172605A5 publication Critical patent/JPWO2020172605A5/ja
Application granted granted Critical
Publication of JP7579795B2 publication Critical patent/JP7579795B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021549484A 2019-02-21 2020-02-21 ＮＫｐ３０に結合する抗体分子およびその使用 Active JP7579795B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962808582P 2019-02-21 2019-02-21
US62/808,582 2019-02-21
PCT/US2020/019329 WO2020172605A1 (fr) 2019-02-21 2020-02-21 Molécules d'anticorps se liant à nkp30 et utilisations associees

Publications (3)

Publication Number Publication Date
JP2022521937A JP2022521937A (ja) 2022-04-13
JPWO2020172605A5 true JPWO2020172605A5 (fr) 2023-06-02
JP7579795B2 JP7579795B2 (ja) 2024-11-08

Family

ID=

Similar Documents

Publication Publication Date Title
CN112534052B (zh) 全新il-21前药及使用方法
JP7282383B2 (ja) タンパク質性ヘテロ二量体及びその用途
WO2017148424A1 (fr) Anticorps anti-pdl-1, composition pharmaceutique et utilisations de celui-ci
AU2020353235A1 (en) Cytokine prodrugs and dual-prodrugs
CN114341189A (zh) 全新il-15前药及其应用
GB2597851A (en) Antibody molecules that bind to NKP30 and uses thereof
EP4017594A1 (fr) Nouveaux promédicaments à base d'il-21 et leurs procédés d'utilisation
WO2021238904A1 (fr) Protéine de fusion fc-cd80, conjugué associé et utilisation correspondante
KR20210107747A (ko) 항체 융합 단백질, 이의 제조 방법 및 이의 적용
JP2023159380A (ja) ＰＤ－１とＴＧＦ－ｂｅｔａを標的とした四価二重特異性抗体、その製造方法および用途
WO2022155541A1 (fr) Promédicaments d'interféron et leurs procédés de fabrication et d'utilisation
CN114786720A (zh) TriAx抗体的组合物及其制备和使用方法
JP2022545234A (ja) Ｃｄ３とｃｄ２０を標的とする二重特異性抗体及びその使用
WO2023045361A1 (fr) Protéine de fusion d'anticorps anti-tigit et d'il2 ou variant de celle-ci et son utilisation
JP2024534545A (ja) インターロイキン２変異体およびその融合タンパク質
JP7510209B2 (ja) ヘルパーＴ細胞ＴＧＦ－βシグナルを特異的に中和する二重特異性抗体、その薬物組成物およびその使用
WO2021244553A1 (fr) Anticorps bispécifique tétravalent contre pd-1 et egfr
JP2024514802A (ja) 二重特異性多機能性融合ポリペプチド
US20220227827A1 (en) Proteinaceous heterodimer and use thereof
JPWO2020172605A5 (fr)
WO2023219120A1 (fr) Anticorps bispécifique anti-ｃｄ３７ et anti-ｃｄ３
WO2022037582A1 (fr) Anticorps bispécifique anti-cd3 et anti-cldn-18.2 et son utilisation
WO2024188319A1 (fr) Anticorps trispécifique anti-muc17, anti-cd3 et anti-cd28
WO2023051727A1 (fr) Anticorps se liant à cd3, et utilisation associée
WO2024193705A1 (fr) Immunocytokine membre de la superfamille du tnf et ses utilisations